Trytosaveabit commented on a stock · May 7, 2024 18:40

Watching for info outa this!

$Connect Biopharma (CNTB.US)$ Connect Biopharma to Present a Late-Breaking Abstract at the American Thoracic Society (ATS) 2024 International Conference on the Positive Results from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe Asthma

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate

Report

5787 Views

Comment

Trytosaveabit

4915

Followers

Following

70K

Visitors